Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-103868
Filing Date
2025-04-29
Accepted
2025-04-29 16:25:44
Documents
24
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d897507ddef14a.htm   iXBRL DEF 14A 481159
6 GRAPHIC g897507dsp1.jpg GRAPHIC 14015
7 GRAPHIC g897507dsp1a.jpg GRAPHIC 92581
8 GRAPHIC g897507dsp1b.jpg GRAPHIC 18652
9 GRAPHIC g897507dsp1c.jpg GRAPHIC 3598
10 GRAPHIC g897507dsp1d.jpg GRAPHIC 3128
11 GRAPHIC g897507dsp1e.jpg GRAPHIC 3569
12 GRAPHIC g897507dsp2.jpg GRAPHIC 1237
13 GRAPHIC g897507dsp2a.jpg GRAPHIC 1520
14 GRAPHIC g897507g02g02.jpg GRAPHIC 60704
  Complete submission text file 0001193125-25-103868.txt   1324772

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eras-20241231.xsd EX-101.SCH 3702
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eras-20241231_def.xml EX-101.DEF 2955
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eras-20241231_lab.xml EX-101.LAB 3219
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eras-20241231_pre.xml EX-101.PRE 2135
26 EXTRACTED XBRL INSTANCE DOCUMENT d897507ddef14a_htm.xml XML 24102
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40602 | Film No.: 25888101
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)